Philips Zoom Take-Home Bulk NiteWhite 16% CP

DIS125/25

Proven results and superb patient experience

Help your patients achieve up to 7 shades whiter teeth in 2 weeks with little-to-no sensitivity.* It is safe for enamel and easy to use. Ideal for patients who prefer whitening overnight.

See all benefits

Philips Zoom Take-Home Bulk NiteWhite 16% CP

Similar products

See all Zoom NiteWhite

Proven results and superb patient experience

Safe, effective and easy-to-use whitening

  • 16% Carbamide Peroxide
Proven up to 7 shades whiter in 2 weeks

Proven up to 7 shades whiter in 2 weeks

The in-vivo clinical study concluded that the use of NiteWhite 16% CP for 14 days resulted in up to 7 shades of colour change.

Proven safe on enamel

Proven safe on enamel

Proven safe on enamel. Professional results your patients can trust

Little-to-no sensitivity* after 14 days of use

Little-to-no sensitivity* after 14 days of use

Designed to prevent tooth sensitivity caused by whitening. Gel contains potassium nitrate and sodium fluoride for patient comfort. 100% of patients confirmed they experienced little-to-no teeth sensitivity* after 14 days of use

Results that patients love

Results that patients love

88% of patients were satisfied with their results*

Dual Barrel technology for reliable whitening

Dual Barrel technology for reliable whitening

Dual Barrel technology keeps active gel and booster agents separate until patients apply gel to the tray for the best balance of efficacy, safety and longevity. This feature maintains the ideal whitening pH, keeps the gel fresh and stable for longer shelf life, and eliminates the need for refrigeration

Technical Specifications

  • Box content

    Number of syringes
    25 (3 treatments per syringe)
    Quick Start Guide
    No
    Tray Case
    No
    Shade guide
    No
    Instructions for use
    Yes
    EVA sheets
    No

Suggested products

Recently viewed products

  • *n=48, USA, 2024. participants using NiteWhite 16% CP once daily for 14 days.
Register

Subscribe to our newsletter

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.